^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

VIM expression

i
Other names: VIM, Vimentin, Epididymis Secretory Sperm Binding Protein
Entrez ID:
Related biomarkers:
2d
Losartan ameliorates renal fibrosis by inhibiting tumor necrosis factor signal pathway. (PubMed, Nefrologia (Engl Ed))
We found that TNF signal pathway was activated in both unilateral ureteral obstruction (UUO) rats and human proximal renal tubular epithelial cells (HK-2) treated with transforming growth factor-β1 (TGF-β1), while losartan can significantly inhibit TNF signal pathway as well as the expression of fibrosis related genes (such as COL-1, α-SMA and Vimentin). These data suggest that losartan may ameliorate renal fibrosis through modulating the TNF pathway.
Review • Journal
|
TNFA (Tumor Necrosis Factor-Alpha) • VIM (Vimentin) • TGFB1 (Transforming Growth Factor Beta 1)
|
VIM expression
4d
EP300 through upregulating the expression of vimentin to promote the progression of chordoma. (PubMed, Neurosurg Focus)
These findings indicate that EP300 functions as an oncogene in chordoma. Targeting EP300 offers a novel approach to the development and clinical treatment of chordoma.
Journal
|
EP300 (E1A binding protein p300) • VIM (Vimentin)
|
VIM expression
|
cisplatin
6d
CD146 Promotes EMT-Mediated Migration and Invasion of NSCLC via PI3K/Akt Signaling Pathway. (PubMed, Front Biosci (Landmark Ed))
CD146 expression acts as a prognostic risk factor for adverse outcomes in NSCLC, promoting invasion and metastasis by activating the EMT through the PI3K/Akt signaling pathway. These findings underscore the potential therapeutic strategies targeting CD146, offering new treatment options for NSCLC patients, especially those at risk of metastasis.
Journal
|
CDH1 (Cadherin 1) • VIM (Vimentin) • MCAM (Melanoma Cell Adhesion Molecule) • CDH2 (Cadherin 2)
|
CDH1 expression • VIM expression
6d
Biological functions of LncRNA SNHG14 in the development of thyroid cancer cells via targeting miR-206. (PubMed, Cell Mol Biol (Noisy-le-grand))
Rescue experiment showed that after BHT101 and Ocut-2C cells were transfected with either sh-lncRNA SNHG14+miR-206-mimics or si-lncRNA SNHG14+miR-206-inhibitor, the cellular proliferative, invasive, and apoptotic activities weren't different from those transfected with siRNA-NC. Suppression of lncRNA SNHG14 up-regulates miR-206 and affects EMT, as well as proliferative, invasive, and apoptotic activities of cells, which may become an underlying treatment target for TC.
Journal
|
CDH1 (Cadherin 1) • VIM (Vimentin) • EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) • CDH2 (Cadherin 2) • MIR206 (MicroRNA 206) • SNAI2 (Snail Family Transcriptional Repressor 2) • TJP1 (Tight Junction Protein 1) • PI3K (Phosphoinositide 3-kinases) • SNHG14 (Small Nucleolar RNA Host Gene 14)
|
CDH1 expression • VIM expression
8d
Parathyroid hormone related-protein (PTHrP) in tissues with poor prognosis in prostate cancer patients. (PubMed, Medicine (Baltimore))
The present study indicates that PTHrP is associated with risk factors of poor outcomes in prostate cancer, while epithelial-mesenchymal transition may be involved in this process.
Journal
|
CDH1 (Cadherin 1) • VIM (Vimentin) • PTHLH (Parathyroid Hormone Like Hormone)
|
CDH1 expression • VIM expression
9d
Epithelial-Mesenchymal Transformation Promotes the Progression of Hepatocellular Carcinoma through NF-κB/MMP9 Axis. (PubMed, Discov Med)
The NF-κB/MMP9 signaling axis serves as a pivotal regulator that fosters proliferation and impedes apoptosis in Huh7 cells by modulating the process of EMT.
Retrospective data • Journal • IO biomarker
|
BCL2 (B-cell CLL/lymphoma 2) • CDH1 (Cadherin 1) • BAX (BCL2-associated X protein) • VIM (Vimentin) • CDH2 (Cadherin 2) • MMP9 (Matrix metallopeptidase 9)
|
BCL2 expression • CDH1 expression • BAX expression • VIM expression
10d
High core 1β1,3-galactosyltransferase 1 expression is associated with poor prognosis and promotes cellular radioresistance in lung adenocarcinoma. (PubMed, J Cancer Res Clin Oncol)
Elevated C1GALT1 expression in LUAD is associated with an unfavorable prognosis and contributes to increased radioresistance potentially by affecting DNA repair, cell proliferation, cell cycle regulation, and epithelial-mesenchymal transition (EMT).
Journal
|
CDH1 (Cadherin 1) • VIM (Vimentin) • CDH2 (Cadherin 2)
|
CDH1 expression • VIM expression
10d
Epithelial-mesenchymal transition dysregulation in prostate cancer: Insights from molecular unraveling and epidemiological analyses in Tunisia, North Africa. (PubMed, Ann Hum Genet)
In summary, understanding these correlations could help develop focused treatment plans and enhance patient outcomes for PCa management in African settings.
Journal
|
CTNNB1 (Catenin (cadherin-associated protein), beta 1) • CDH1 (Cadherin 1) • VIM (Vimentin) • ITK (IL2 Inducible T Cell Kinase) • ZEB1 (Zinc Finger E-box Binding Homeobox 1)
|
VIM expression • ZEB1 expression
10d
Prolactin-induced tyrosyl phosphorylation of PAK1 facilitates epithelial-mesenchymal transition. (PubMed, MicroPubl Biol)
pTyr-PAK1 also significantly increases PRL-dependent Slug activity leading to expression of vimentin, a hallmark of EMT. Thus, our current data on pTyr-PAK1 regulation of EMT bring insight into the role of PAK1 and PRL in human breast cancer.
Journal
|
JAK2 (Janus kinase 2) • CDH1 (Cadherin 1) • VIM (Vimentin) • SNAI2 (Snail Family Transcriptional Repressor 2)
|
CDH1 expression • VIM expression
12d
Kinesin Facilitates Phenotypic Targeting of Therapeutic Resistance in Advanced Prostate Cancer. (PubMed, Mol Cancer Res)
Combinational targeting of kinesins (ispinesib) with cabazitaxel was more effective than single monotherapies in inducing cell death in resistant prostate tumors. Implications: Our findings are of translational significance in identifying kinesin as a novel target of cross-resistance, towards enhancing therapeutic vulnerability and improved clinical outcomes in patients with advanced prostate cancer.
Journal • Metastases
|
CDH1 (Cadherin 1) • SLCO1B3 (Solute carrier organic anion transporter family member 1B3) • VIM (Vimentin) • KIFC1 (Kinesin Family Member C1)
|
CDH1 expression • VIM expression • CDH1 overexpression
|
cabazitaxel • ispinesib (SB-715992)
17d
Identification of functional and diverse circulating cancer-associated fibroblasts in metastatic castration-naïve prostate cancer patients. (PubMed, Mol Oncol)
Two cCAF subpopulations, FAP+CD45- and FAP+CD45+, were identified, both expressing collagen-I and vimentin, but with distinctly different morphologies. Collectively, this study demonstrates the presence of functional and viable circulating CAFs in mCNPC patients, suggesting the role of these cells in prostate cancer.
Journal • Metastases
|
PTPRC (Protein Tyrosine Phosphatase Receptor Type C) • EPCAM (Epithelial cell adhesion molecule) • VIM (Vimentin)
|
VIM expression
18d
Lectin-Based Immunophenotyping and Whole Proteomic Profiling of CT-26 Colon Carcinoma Murine Model. (PubMed, Int J Mol Sci)
Galectin-1 and S100A4 were identified as upregulated proteins in the primary and secondary CT26 tumor tissues, and these were previously reported to contribute to the poor prognosis of CRC patients. Modelling the development of liver colonization of CRC by the injection of CT26 cells into the spleen may facilitate the understanding of carcinogenesis in human CRC and contribute to the development of novel therapeutic strategies.
Preclinical • Journal
|
LGALS1 (Galectin 1) • VIM (Vimentin) • ITGAM (Integrin, alpha M) • LGALS3 (Galectin 3) • S100A4 (S100 calcium binding protein A4)
|
VIM expression
18d
Monochasma Savatieri Aqueous Extract inhibits Human Breast Cancer Cell Line Migration and Adhesion Without Generating Toxicity. (PubMed, Anticancer Agents Med Chem)
M. savatieri possesses anti-cancer activity without exerting cytotoxicity on breast cancer cells. The extract exhibited anti-migratory and anti-adhesion effects on breast cancer cells by regulating Erk and Akt signaling pathways and the expression of caveolin-1. In addition, acteoside present in M. savatieri could be responsible for the observed effects.
Preclinical • Journal
|
CAV1 (Caveolin 1) • VIM (Vimentin)
|
VIM expression • CAV1 expression
19d
Phenotypic Heterogeneity of Cancer Associated Fibroblasts in Cervical Cancer Progression: FAP as a Central Activation Marker. (PubMed, Cells)
In the early stages, a myofibroblast-like phenotype (CAFs αSMA+ FAP+), and in the late stages a protumoral phenotype (CAF αSMA- FAP+). In summary, FAP has a crucial role in the activation of CAFs during cervical cancer progression.
Journal
|
VIM (Vimentin) • FAP (Fibroblast activation protein, alpha) • MMP9 (Matrix metallopeptidase 9) • S100A4 (S100 calcium binding protein A4)
|
FAP expression • VIM expression
19d
Edible wild plants, chicory and purslane, alleviated diabetic testicular dysfunction, and insulin resistance via suppression 8OHdg and oxidative stress in rats. (PubMed, PLoS One)
The histological studies provided evidence supporting the preventive effects of Ch and Pu against DM-induced testicular dysfunction. In conclusion, Ch and Pu seed-extracts mitigate testicular impairment during DM due to their antihyperglycemic, antilipidemic, antioxidant, anti-inflammatory, and antiapoptotic properties.
Preclinical • Journal • IO biomarker
|
BCL2 (B-cell CLL/lymphoma 2) • IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • CASP3 (Caspase 3) • VIM (Vimentin) • CAT (Catalase) • CRP (C-reactive protein)
|
BCL2 expression • VIM expression
20d
Congenital localized cutaneous Langerhans cell histiocytosis in a Holstein calf. (PubMed, J Vet Diagn Invest)
The masses were diagnosed as Langerhans cell histiocytosis. Congenital cutaneous Langerhans cell histiocytosis has not been reported previously in cattle, to our knowledge, and should be included in the differential diagnosis of congenital nodular skin lesions.
Journal
|
CDH1 (Cadherin 1) • VIM (Vimentin) • ITGB2 (Integrin Subunit Beta 2) • MSR1 (Macrophage Scavenger Receptor 1)
|
CDH1 expression • VIM expression
23d
The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study. (PubMed, Front Immunol)
Efficacy of NLGP was tested first time in sequential carcinogenesis model and proved effective in delaying the initial progression. NLGP normalizes type 1 immunity including activation of the CD8+T effector functions, reduction of regulatory T cell functions, along with changes in EMT to make the host systemically alert to combat the carcinogenic threat.
Preclinical • Journal • Immunomodulating
|
CD8 (cluster of differentiation 8) • IFNG (Interferon, gamma) • IL6 (Interleukin 6) • CDH1 (Cadherin 1) • CD4 (CD4 Molecule) • IL2 (Interleukin 2) • VIM (Vimentin) • GZMB (Granzyme B) • CD31 (Platelet and endothelial cell adhesion molecule 1) • FOXP3 (Forkhead Box P3) • MMP9 (Matrix metallopeptidase 9) • ITGAX (Integrin Subunit Alpha X) • PECAM1 (Platelet And Endothelial Cell Adhesion Molecule 1)
|
VIM expression
24d
Downregulation of SETDB1 suppresses epithelial mesenchymal transition and invasion and metastasis in oral cancer via SOX7 methylation (PubMed, Shanghai Kou Qiang Yi Xue)
Downregulation of SETDB1 could suppress EMT, migration and invasion of oral cancer cells by regulating SOX7 methylation level, providing new ideas and targets for the diagnosis and treatment of oral cancer.
Journal
|
CTNNB1 (Catenin (cadherin-associated protein), beta 1) • VIM (Vimentin) • CDH2 (Cadherin 2) • SETDB1 (SET Domain Bifurcated Histone Lysine Methyltransferase 1) • SNAI2 (Snail Family Transcriptional Repressor 2)
|
VIM expression
24d
Arsenic and Benzo[a]pyrene Co-exposure Effects on MDA-MB-231 Cell Viability and Migration. (PubMed, Biol Trace Elem Res)
However, there were no observable changes in the expression of E-cadherin mRNA. Consequently, additional research is required to evaluate the prolonged effects of co-exposure to As and BaP on the initiation of EMT and the progression of breast cancer.
Journal
|
BAP1 (BRCA1 Associated Protein 1) • CDH1 (Cadherin 1) • VIM (Vimentin)
|
CDH1 expression • VIM expression
24d
A novel four‑gene biomarker for tobacco smoking -induced colorectal cancer progression. (PubMed, Nicotine Tob Res)
This study demonstrates tobacco-derived NNK dependence would promote the malignant progression of colorectal cancer through regulating the expressions of AKR1B10/Wnt signaling pathway. And a novel four-gene signature is established for the prognosis prediction of smoking CRC patients. These findings have important translational implications given the continued use of tobacco and the difficulty in smoking cessation worldwide, which can be applied to alleviate the adverse effects induced by tobacco dependence on colorectal cancer patients.
Journal
|
CTNNB1 (Catenin (cadherin-associated protein), beta 1) • CDH1 (Cadherin 1) • VIM (Vimentin) • CDH2 (Cadherin 2) • AKR1B10 (Aldo-Keto Reductase Family 1 Member B10) • CALB2 (Calbindin 2)
|
CDH1 expression • VIM expression
24d
Lutein inhibits the adhesion, invasiveness and metastasis of human prostate cancer PC-3M cells (PubMed, Zhonghua Nan Ke Xue)
Lutein can inhibit cell adhesion, reduce the expressions of MMPs, and suppress cell invasion and migration by inhibiting the process of epithelial-mesenchymal transition.
Journal
|
CDH1 (Cadherin 1) • MMP2 (Matrix metallopeptidase 2) • TIMP1 (Tissue inhibitor of metalloproteinases 1) • VIM (Vimentin) • CDH2 (Cadherin 2) • MMP9 (Matrix metallopeptidase 9) • PXN (Paxillin)
|
CDH1 expression • VIM expression • TIMP1 expression
26d
Misleading clinical and imaging features in atypical aggressive angiomyxoma of the female vulvovaginal or perianal region: report of three cases and review of the literature. (PubMed, Front Oncol)
US reveals a well-defined hypoechoic to anechoic mass with uniformly distributed coarse dot echoes, with or without detectable intratumoral blood flow signal. MRI shows prolonged T1 and T2 signals with inhomogeneous enhancement and evident diffusion restriction on diffusion-weighted imaging (DWI).
Review • Journal
|
PGR (Progesterone receptor) • VIM (Vimentin)
|
VIM expression
29d
Degradation of FAK-targeting by proteolytic targeting chimera technology to inhibit the metastasis of hepatocellular carcinoma. (PubMed, Oncol Res)
Increased expression of E-cadherin and decreased expression of vimentin indicated that EMT was inhibited. Consequently, degradation of FAK through FAK PROTAC effectively suppressed liver cancer metastasis, holding significant clinical implications for treating liver cancer and developing innovative anti-neoplastic drugs.
Journal
|
CDH1 (Cadherin 1) • VIM (Vimentin) • PTK2 (Protein Tyrosine Kinase 2)
|
CDH1 expression • VIM expression
30d
MiR-383-5p inhibits the proliferation and migration of lung adenocarcinoma cells by targeting SHMT2. (PubMed, J Cancer)
Exogenous overexpression of SHMT2 reversed the miR-383-5p-induced proliferation and migration inhibition in A549 and H1299 cells. MiR-383-5p inhibits the proliferation and migration of lung adenocarcinoma cells by targeting and downregulating SHMT2.
Journal • IO biomarker
|
BCL2 (B-cell CLL/lymphoma 2) • CCND1 (Cyclin D1) • CDH1 (Cadherin 1) • VIM (Vimentin) • CDH2 (Cadherin 2) • MIR383 (MicroRNA 383) • SHMT2 (Serine Hydroxymethyltransferase 2)
|
CCND1 expression • CDH1 expression • VIM expression
1m
Suppression of JAK2/STAT3 Pathway by Notoginsenoside R1 Reduces Epithelial-Mesenchymal Transition in Non-small Cell Lung Cancer. (PubMed, Mol Biotechnol)
Moreover, a specific inhibitor of JAK2, AG490, or STAT3 silencing significantly enhanced the effects of NGR1 against the EMT process in NSCLC cells. NGR1 restrains EMT process in NSCLC by inactivating JAK2/STAT3 signaling, suggesting the potential of NGR1 in anti-NSCLC therapy.
Journal
|
CDH1 (Cadherin 1) • VIM (Vimentin) • TGFB1 (Transforming Growth Factor Beta 1) • CDH2 (Cadherin 2) • SNAI1 (Snail Family Transcriptional Repressor 1)
|
CDH1 expression • VIM expression
1m
Tetrastigma hemsleyanum (Sanyeqing) root extracts evoke S phase arrest while inhibiting the migration and invasion of human pancreatic cancer PANC-1 cells. (PubMed, BMC Complement Med Ther)
Treatment of PANC-1 with EFT demonstrated measurable cytotoxic effects. Furthermore, EFT evoked S phase arrest while inhibiting the migration and invasion of PANC-1 cells. Additionally, EFT inhibited the epithelial to mesenchymal transition and MMPs expression in PANC-1 cells. This study serves to confirm the strong therapeutic potential of EFT while identifying the mechanisms of action.
Journal
|
CDH1 (Cadherin 1) • MMP2 (Matrix metallopeptidase 2) • FN1 (Fibronectin 1) • VIM (Vimentin) • CDK2 (Cyclin-dependent kinase 2) • CDH2 (Cadherin 2) • MMP9 (Matrix metallopeptidase 9) • ZEB1 (Zinc Finger E-box Binding Homeobox 1)
|
CDH1 expression • VIM expression
1m
Journal
|
IFNG (Interferon, gamma) • IL10 (Interleukin 10) • VIM (Vimentin) • IL17A (Interleukin 17A)
|
VEGFA expression • VIM expression
1m
Functional Selectivity of Cannabinoid Type 1 G Protein-Coupled Receptor Agonists in Transactivating Glycosylated Receptors on Cancer Cells to Induce Epithelial-Mesenchymal Transition Metastatic Phenotype. (PubMed, Cells)
This approach was further substantiated by findings that the neuromedin B receptor inhibitor, BIM-23127, MMP-9 inhibitor, MMP9i, and Neu-1 inhibitor, oseltamivir phosphate, could specifically block CB1 agonist-induced Neu-1 sialidase activity...Moreover, the study results demonstrate that CB1 agonists induce NFκB-dependent secretory alkaline phosphatase (SEAP) activity in influencing the expression of epithelial-mesenchymal markers, E-cadherin, and vimentin in SW-620 cells, albeit the impact on E-cadherin expression is less pronounced compared to vimentin. In essence, this innovative research begins to elucidate an entirely new molecular mechanism involving a GPCR signaling paradigm in which cannabinoids, as epigenetic stimuli, may traverse to influence gene expression and contribute to cancer and cancer metastasis.
Journal • Metastases
|
CDH1 (Cadherin 1) • VIM (Vimentin) • MMP9 (Matrix metallopeptidase 9)
|
CDH1 expression • VIM expression
1m
The analysis of boric acid effect on epithelial-mesenchymal transition of CD133 + CD117 + lung cancer stem cells. (PubMed, Naunyn Schmiedebergs Arch Pharmacol)
Moreover, while E-cadherin (p < 0.001) and Collagen-1 (p < 0.01) immunoreactivities significantly increased, MMP-3 (p < 0.001) and Vimentin (p < 0.01) immunoreactivities decreased in BA-treated LC-SCs. To conclude, the current study provided insights into the efficacy and effects of BA against LC-SCs regarding proliferation, EMT, and cell death for future studies.
Journal • Cancer stem
|
KIT (KIT proto-oncogene, receptor tyrosine kinase) • CDH1 (Cadherin 1) • VIM (Vimentin) • COL1A1 (Collagen Type I Alpha 1 Chain) • SNAI1 (Snail Family Transcriptional Repressor 1) • ZEB1 (Zinc Finger E-box Binding Homeobox 1) • ITGA5 (Integrin Subunit Alpha 5) • ITGB1 (Integrin Subunit Beta 1) • MMP3 (Matrix metallopeptidase 3)
|
VIM expression • ZEB1 expression
1m
Long non-coding RNA H19 mediates the miR-29b/transforming growth factor-β1/Drosophila mothers against decapentaplegic 3 signalling pathway to promote bladder fibrosis in diabetic rats. (PubMed, Int Urol Nephrol)
This study indicated that LncRNA H19 may inhibit bladder fibrosis in diabetic rats by targeting miR-29b via the TGF-β1/Smad3 signalling pathway.
Preclinical • Journal
|
SMAD4 (SMAD family member 4) • CDH1 (Cadherin 1) • VIM (Vimentin) • TGFB1 (Transforming Growth Factor Beta 1) • CDH2 (Cadherin 2) • H19 (H19 Imprinted Maternally Expressed Transcript) • SMAD3 (SMAD Family Member 3)
|
CDH1 expression • VIM expression
1m
Bioactive solanidane steroidal alkaloids from Solanum lyratum. (PubMed, Fitoterapia)
These findings indicate that lyrasolanoside B (2) inhibits the metastasis of A549 cells by suppressing exosome-mediated EMT. These findings suggest that lyrasolanoside B (2) may inhibit the metastasis of lung cancer by regulating A549-derived exosomes.
Journal
|
CDH1 (Cadherin 1) • VIM (Vimentin) • CDH2 (Cadherin 2)
|
CDH1 expression • VIM expression
1m
Knocking Down HN1 Blocks Helicobacter pylori-Induced Malignant Phenotypes in Gastric Mucosal Cells and Inhibits Gastric Cancer Cell Proliferation, Cytoskeleton Remodeling, and Migration. (PubMed, Biochem Genet)
Our research demonstrated the crucial role of HN1 in H. pylori-induced acquisition of a malignant phenotype in GES-1 cells. Knockdown of HN1 blocked the pathogenic mechanism of H. pylori-induced GC and downregulated the expression of GSK3Β, β-catenin and Vimentin via Integrin β1.
Journal
|
CTNNB1 (Catenin (cadherin-associated protein), beta 1) • VIM (Vimentin) • GSK3B (Glycogen Synthase Kinase 3 Beta) • JPT1 (Jupiter Microtubule Associated Homolog 1)
|
VIM expression
1m
Plumbagin Regulates Snail to Inhibit Hepatocellular Carcinoma Epithelial-Mesenchymal Transition in vivo and in vitro. (PubMed, J Hepatocell Carcinoma)
In vitro experiments confirmed that PL up-regulated epithelial cell markers, down-regulated mesenchymal cell markers, and inhibited EMT levels in HCC cells. PL inhibits Snail expression, up-regulates E-cadherin expression, and down-regulates N-cadherin and vimentin expression, preventing EMT in HCC cells and reducing lung metastasis.
Preclinical • Journal
|
CDH1 (Cadherin 1) • VIM (Vimentin) • TGFB1 (Transforming Growth Factor Beta 1) • CDH2 (Cadherin 2) • SNAI1 (Snail Family Transcriptional Repressor 1)
|
CDH1 expression • VIM expression
1m
Extracellular vesicles derived from dendritic cells loaded with VEGF-A siRNA and doxorubicin reduce glioma angiogenesis in vitro. (PubMed, J Control Release)
DC-EVs loaded with VEGF-A siRNA and Doxorubicin were more potent than BV alone as a multi-disciplinary strategy that combats glioma growth by cytotoxic impacts of DOX and inhibits angiogenesis by VEGF-A siRNAs with excess immunologic benefits from DC-EVs. This next-generation anti-angiogenic agent normalizes tumor vessel density rather than extensively eliminating tumor vessels causing hypoxia and mesenchymal transition.
Preclinical • Journal
|
CD8 (cluster of differentiation 8) • VEGFA (Vascular endothelial growth factor A) • VIM (Vimentin)
|
VIM expression
|
doxorubicin hydrochloride
1m
Circular RNA hsa_circ_0051246 acts as a microRNA-375 sponge to promote the progression of gastric cancer stem cells via YAP1. (PubMed, PeerJ)
Importantly, circ_0051246 knockdown and miR-375 activation suppressed CSC tumorigenicity in vivo. This study highlights the promotion of circ_0051246-miR-375-YAP1 axis activation in GC progression and provides a scientific basis for research on the molecular mechanism of CSCs.
Journal • Cancer stem • Circular RNA
|
CDH1 (Cadherin 1) • YAP1 (Yes associated protein 1) • VIM (Vimentin) • CDH2 (Cadherin 2) • JAG1 (Jagged Canonical Notch Ligand 1) • MIR375 (MicroRNA 375)
|
CDH1 expression • VIM expression • YAP1 overexpression
1m
S100A6 mediated epithelial-mesenchymal transition affects chemosensitivity of colorectal cancer to oxaliplatin. (PubMed, Gene)
In conclusion, the knockdown of S100A6 may overcome the L-OHP resistance of CRC cells by modulating EMT.
Journal
|
VIM (Vimentin) • TGFB1 (Transforming Growth Factor Beta 1) • S100A6 (S100 calcium binding protein A6)
|
VIM expression
|
oxaliplatin
1m
Overexpression of BZW1 promotes invasion and metastasis of gastric cancer cells by regulating Wnt/β-catenin signaling and promoting epithelial-mesenchymal transition (PubMed, Nan Fang Yi Ke Da Xue Xue Bao)
BZW1 is highly expressed in gastric cancer tissues to affect the patient prognosis possibly by activation the Wnt/β-catenin signaling pathway to promote EMT of gastric cancer cells.
Journal
|
MYC (V-myc avian myelocytomatosis viral oncogene homolog) • CDH1 (Cadherin 1) • VIM (Vimentin) • CDH2 (Cadherin 2) • CA 19-9 (Cancer antigen 19-9)
|
MYC expression • CDH1 expression • VIM expression
1m
Demethylzeylasteral inhibits proliferation, migration and invasion and promotes apoptosis of non-small cell lung cancer cells by inhibiting the AKT/CREB signaling pathway (PubMed, Nan Fang Yi Ke Da Xue Xue Bao)
T-96 inhibits the proliferation, migration and invasion and induces apoptosis of NSCLC cells possibly by inhibiting the AKT/CREB signaling pathway.
Journal • IO biomarker
|
BCL2 (B-cell CLL/lymphoma 2) • CDH1 (Cadherin 1) • BAX (BCL2-associated X protein) • CASP3 (Caspase 3) • VIM (Vimentin) • CDH2 (Cadherin 2)
|
BCL2 expression • CDH1 expression • BAX expression • VIM expression
1m
Thiazolyl-isatin derivatives: Synthesis, in silico studies, in vitro biological profile against breast cancer cells, mRNA expression, P-gp modulation, and interactions of Akt2 and VIM proteins. (PubMed, Chem Biol Interact)
Compounds 4a and 4c significantly decreased P-gp mRNA expression levels in MCF-7, 4 and 2 folds respectively. Regarding the impact on tumorigenic signaling proteins, compound 4a inhibited Akt2 in MDA-MB-231 and compound 4c inhibited the mRNA expression of VIM in MCF-7.
Preclinical • Journal
|
VIM (Vimentin) • AKT2 (V-akt murine thymoma viral oncogene homolog 2)
|
VIM expression
1m
Expression and clinical significance of NEK2 and EMT related molecules in oral squamous cell carcinoma (PubMed, Shanghai Kou Qiang Yi Xue)
NEK2 can be used as a prognostic marker for OSCC. The up-regulation of NEK2 and the changes in the expression levels of EMT related molecules can promote the occurrence and development of OSCC.
Journal
|
CDH1 (Cadherin 1) • VIM (Vimentin) • CDH2 (Cadherin 2) • NEK2 (NIMA Related Kinase 2)
|
CDH1 expression • VIM expression
1m
Regulatory mechanism of the Glabrene against non-small cell lung cancer by suppressing FGFR3. (PubMed, Environ Toxicol)
Glabrene has the potential as a therapeutic agent for NSCLC by reducing cancer invasion and migration through the inhibition of ERK1/2 phosphorylation and suppression of epithelial-mesenchymal transition (EMT).
Journal
|
FGFR3 (Fibroblast growth factor receptor 3) • CDH1 (Cadherin 1) • IGF1 (Insulin-like growth factor 1) • VIM (Vimentin) • MMP9 (Matrix metallopeptidase 9) • MMP1 (Matrix metallopeptidase 1)
|
FGFR3 overexpression • CDH1 expression • FGFR3 expression • VIM expression • FGF3 overexpression
1m
Exercise affects high-fat diet-stimulated breast cancer metastasis through irisin secretion by altering cancer stem cell properties. (PubMed, Biochem Biophys Rep)
Steady exercise modulates myokine secretions and among them, irisin suppresses breast cancer metastasis by decreasing self-renewal properties and invasion regulating protein expressions. Thus, regular exercise may be beneficial in the prevention of breast tumor metastasis.
Journal • Cancer stem
|
HIF1A (Hypoxia inducible factor 1, alpha subunit) • MMP2 (Matrix metallopeptidase 2) • TIMP1 (Tissue inhibitor of metalloproteinases 1) • VIM (Vimentin) • TIMP2 (TIMP Metallopeptidase Inhibitor 2) • MMP9 (Matrix metallopeptidase 9)
|
HIF1A expression • VIM expression • TIMP1 expression